Project Details
| Status | Active |
|---|---|
| Effective start/end date | 30/10/25 → 29/10/30 |
Clinical Trial Phase
- Phase II
- External Sponsor
A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 years) with Non-cystic Fibrosis Bronchiectasis
- King, Paul (Primary Chief Investigator (PCI))
Project: Research